Clinical Safety of Combined Targeted and Viscum album L. Therapy in Oncological Patients

Clinical Safety of Combined Targeted and Viscum album L. Therapy in Oncological Patients

Background: Despite improvement of tumor response rates, targeted therapy may induce toxicities in cancer patients. Recent studies indicate amelioration of adverse events (AEs) by add-on mistletoe (Viscum album L., VA) in standard oncological treatment. The primary objective of this multicenter obse...

Full description

Bibliographic Details
Main Authors: Anja Thronicke, Shiao Li Oei, Antje Merkle, Harald Matthes, Friedemann Schad
Format: Article
Language:English
Published: MDPI AG 2018-09-01
Series:Medicines
Subjects:
safety analysis
toxicity profile
combinational therapy
targeted therapy
monoclonal antibody therapy
immune checkpoint inhibitors
treatment discontinuation
Viscum album L.
Online Access:http://www.mdpi.com/2305-6320/5/3/100

Internet

http://www.mdpi.com/2305-6320/5/3/100

Similar Items